Transplacental action of sodium nitrite on embryonic cells of Syrian golden hamster.
Hamster embryos were treated with various doses of NaNO2 in utero, by its oral administration to the mothers, and then the embryonic cells were examined for micronucleus formation, chromosomal aberrations, morphological or malignant transformation and drug-resistant mutations. For induction of resistant mutations, the cells were cultured in normal medium for 72 h, and then selected in media containing 8-azaguanine (10 or 20 microgram/ml) or 1 mM ouabain. This treatment with NaNO2 caused marked dose-dependent induction of 8-azaguanine- and ouabain-resistant mutations. Cultured embryonic fibroblasts in the resting state also showed a marked dose-dependent increase in micronucleus formation but not an increase in chromosomal aberrations. This treatment also caused morphological and neoplastic transformation of the cells. Transplacental oral treatment with DMN, as a positive control, caused changes of similar extent in biological effects of embryonic fibroblasts, and in addition it caused chromosomal aberrations in metaphase plates. On the contrary, transplacental oral application of NaNO2 did not induce any biological change in cultured embryonic fibroblasts.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001375:Azaguanine / Q000494:pharmacology; D002273:Carcinogens; D002471:Cell Transformation, Neoplastic; D002869:Chromosome Aberrations; D006224:Cricetinae; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D008431:Maternal-Fetal Exchange; D008647:Mesocricetus; D009153:Mutagens; D009573:Nitrites / Q000633:toxicity*; D010042:Ouabain / Q000494:pharmacology; D011247:Pregnancy; D012977:Sodium Nitrite / Q000633:toxicity*; D013723:Teratogens
D002273:Carcinogens; D009153:Mutagens; D009573:Nitrites; D013723:Teratogens; D010042:Ouabain; D012977:Sodium Nitrite; D001375:Azaguanine